Breaking News, Collaborations & Alliances

Ono, Admid Partner on Novel Antibody Drugs in Oncology

Ono will evaluate and develop antibody product candidates at the preclinical and clinical stages.

Ono Pharmaceutical Co., Ltd., entered into a drug discovery collaboration agreement with Adimab, LLC, a company involved in the discovery and optimization of fully human monoclonal and bispecific antibodies, to discover and develop innovative antibody drugs in the oncology field. Under the terms of the agreement, Adimab will discover novel therapeutic antibodies against multiple targets selected by Ono and generate bispecific antibody product candidates. Ono will evaluate and develop such can...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters